1. Oridonin Targets Multiple Drug-Resistant Tumor Cells as Determined by in Silico and in Vitro Analyses
   Onat Kadioglu et al, 2018, Front. Pharmacol. CrossRef
2. Contribution of Epithelial Plasticity to Therapy Resistance
   Patricia G. Santamaría et al, 2019, JCM CrossRef
3. ROS1-fusion protein induces PD-L1 expression via MEK-ERK activation in non-small cell lung cancer
   Zheng Liu et al, 2020, OncoImmunology CrossRef
4. MERTK Inhibition: Potential as a Treatment Strategy in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer
   Chao-Ju Chen et al, 2021, Pharmaceuticals CrossRef
5. Trilobatin Induces Apoptosis and Attenuates Stemness Phenotype of Acquired Gefitinib Resistant Lung Cancer Cells via Suppression of NF-κB Pathway
   Wang Li et al, 2021, Nutrition and Cancer CrossRef
6. Bruceine H Mediates EGFR-TKI Drug Persistence in NSCLC by Notch3-Dependent β-Catenin Activating FOXO3a Signaling
   Jiahui Wu et al, 2022, Front. Oncol. CrossRef
7. Afatinib plus PEM and CBDCA overcome osimertinib resistance in EGFR‐mutated NSCLC with high thrombospondin‐1 expression
   Naomi Onda et al, 2024, Cancer Science CrossRef